ArticleFrontiers in public health2024
Association of hemoglobin levels with cause-specific and all-cause mortality among older adults: a prospective cohort study.
Article in Frontiers in public health, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
2 citing papers in PubMed.
- Associations Between Hematologic Parameters and All-Cause Death in Individuals With Cardio-Renal-Metabolic Multimorbidity: A National Cohort Study.Journal of the American Heart Association · 2025Article
- Assessment of Mortality Risk in Patients With Community-Acquired Pneumonia: Role of Novel Inflammatory Biomarkers.Journal of clinical laboratory analysis · 2025Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
6 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Background: Hemoglobin (Hb) optimal levels is clinically and biologically heterogeneous, data of older adults was not available. Methods: We used data of participants enrolled in Shenzhen Healthy Ageing Research, in which the baseline Hb was measured in 223,407 older adults aged 65 or older to evaluation of Hb optimal levels. The vital status of the participants by 31 December, 2021 was determined. We estimated the hazard ratios with 95% confidence intervals for all-cause or cause-specific mortality using multivariable Cox proportional hazards models, and Cox models with restricted cubic spline (RCS) was used for all-cause mortality. Results: Overall, 6,722 deaths occurred during a mean follow-up of 3.01 years from 2018 to 2021. The risk for all-cause and cause-specific mortality was significantly lower in males with Hb levels of ≥14.0 g/dL. The Hb range in which the lowest hazard ratios for the female all-cause or cardiovascular disease mortality were observed in our study was 12.0-14.9 g/dL and 11.0-14.9 g/dL, respectively. For the female participants observed higher Hb levels were significantly associated with lower risk of cancer-cause mortality (≥12.0 g/dL) or other-cause mortality (≥11.0 g/dL). The results from RCS curve showed similar results. Conclusion: Considering the risk of mortality, we recommended ≥14.0 g/dL and 12-14.9 g/dL as the optimal range of Hb among Chinese male and female older adults, respectively.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.